Chronic systemic CBD treatment showed different effects on neuropathic pain sensitivity depending on whether rats were bred for high or low anxiety-related freezing behavior.
Pain researchers, anxiety disorder specialists, cannabinoid pharmacologists, and personalized medicine advocates.
Phenotype mattersCBD pain effects varied between anxiety-prone and anxiety-resistant rat lines
What the researchers found
CBD treatment effects on neuropathic pain varied by anxiety phenotype, with rats bred for high conditioned freezing (anxiety-prone) showing different pain sensitivity responses than low-freezing rats, supporting the anxiety-pain comorbidity framework.
Why it matters
The high comorbidity between anxiety and chronic pain suggests shared mechanisms. Understanding how CBD affects pain differently based on anxiety phenotype could lead to more personalized treatment approaches.
The numbers in context
The study used Carioca High-Conditioned Freezing (CHF) and Low-Conditioned Freezing (CLF) rat lines in a neuropathic pain model with chronic systemic CBD.
How the study worked
Preclinical study using selectively bred rat lines (high vs low anxiety) to evaluate chronic CBD effects on neuropathic pain sensitivity.
Who was studied
Carioca High- and Low-Conditioned Freezing rats in a neuropathic pain model.
What this study cannot tell us
Selectively bred rat lines may not represent the full spectrum of human anxiety-pain comorbidity; chronic systemic CBD dosing may not reflect clinical use patterns; animal pain models have inherent limitations.
How to read the evidence
Preclinical study with selective breeding model; provides mechanistic insight but requires clinical translation.
When this study was published
Recent preclinical study on anxiety-pain-CBD interactions.
The bigger picture
This research supports the concept that the same treatment may work differently depending on an individuals underlying anxiety profile, advancing the case for personalized cannabinoid therapeutics.
Replication
Novel use of selectively bred anxiety lines for CBD-pain research; adds to phenotype-dependent treatment response literature.
Funding
Not specified
Conflicts of interest
Not specified
Questions still open
- What mechanisms drive the phenotype-dependent CBD response?
- Could anxiety screening predict CBD treatment outcomes for pain?
- Do these findings apply to other cannabinoids?
Read the original research
Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity.
Pharmaceuticals (Basel, Switzerland), 16(7)
Citation
Macêdo-Souza, Carolina; Maisonnette, Silvia Soares; Hallak, Jaime E; Crippa, José A; Zuardi, Antônio W; Landeira-Fernandez, J; Leite-Panissi, Christie Ramos Andrade. (2023). Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity.. Pharmaceuticals (Basel, Switzerland), 16(7). https://doi.org/10.3390/ph16071003